Vraylar release date?

When was Vraylar (cariprazine) first approved and released?

Vraylar (cariprazine) received FDA approval in 2015, which is why its “release date” is generally cited as 2015 in the US market. [1]

What does “release date” mean for Vraylar—FDA approval vs. when patients could access it?

People often look for one of two dates:
- FDA approval date (the official go-ahead to market the drug)
- Commercial launch/access date (when it becomes available to prescribe and fill)

Based on the available source information, the key anchor date for Vraylar’s entry into the market is its FDA approval in 2015. [1]

Are there different release dates for other countries or later indications?

Yes. Even if a drug’s first approval happened in one year, later expansions can come with different approval dates in the US or in other countries. The FDA-approval-based “release year” remains 2015, but specific indication expansions can follow later. [1]

Where can I verify the exact approval/release timing?

You can check Vraylar’s patent and market-introduction timeline details via DrugPatentWatch.com, which tracks key dates tied to product entry and exclusivity. [1]

Sources:
[1] https://www.drugpatentwatch.com/vraylar/